Adelene Q Perkins - Net Worth and Insider Trading

Adelene Q Perkins Net Worth

The estimated net worth of Adelene Q Perkins is at least $0 dollars as of 2024-11-05. Adelene Q Perkins is the Director of Infinity Pharmaceuticals Inc and owns about 1,191,738 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $0. Details can be seen in Adelene Q Perkins's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adelene Q Perkins has not made any transactions after 2023-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Adelene Q Perkins

To

Adelene Q Perkins Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Adelene Q Perkins owns 2 companies in total, including Infinity Pharmaceuticals Inc (INFIQ) , and Bruker Corp (BRKR) .

Click here to see the complete history of Adelene Q Perkins’s form 4 insider trades.

Insider Ownership Summary of Adelene Q Perkins

Ticker Comapny Transaction Date Type of Owner
INFIQ Infinity Pharmaceuticals Inc 2023-09-12 director & President & CEO
BRKR Bruker Corp 2017-05-22 director

Adelene Q Perkins Latest Holdings Summary

Adelene Q Perkins currently owns a total of 1 stock. Adelene Q Perkins owns 1,191,738 shares of Infinity Pharmaceuticals Inc (INFIQ) as of September 12, 2023, with a value of $0.

Latest Holdings of Adelene Q Perkins

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INFIQ Infinity Pharmaceuticals Inc 2023-09-12 1,191,738 0.00 0

Holding Weightings of Adelene Q Perkins


Adelene Q Perkins Form 4 Trading Tracker

According to the SEC Form 4 filings, Adelene Q Perkins has made a total of 1 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 410,196 shares on September 12, 2023, which brought Adelene Q Perkins around $28,714.

Insider Trading History of Adelene Q Perkins

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Adelene Q Perkins Trading Performance

GuruFocus tracks the stock performance after each of Adelene Q Perkins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adelene Q Perkins is 6.24%. GuruFocus also compares Adelene Q Perkins's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adelene Q Perkins within 3 months outperforms 6 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Adelene Q Perkins's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Adelene Q Perkins

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.74 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.79 LIMIT LIMIT LIMIT LIMIT LIMIT

Adelene Q Perkins Ownership Network

Ownership Network List of Adelene Q Perkins

No Data

Ownership Network Relation of Adelene Q Perkins

Insider Network Chart

Adelene Q Perkins Owned Company Details

What does Infinity Pharmaceuticals Inc do?

Who are the key executives at Infinity Pharmaceuticals Inc?

Adelene Q Perkins is the director & President & CEO of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include Chief Scientific Officer Stephane Peluso , Chief Medical Officer Robert Jr. Ilaria , and other: See Explanation of Responses Biotechnology Value Fund L P .

Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary

Over the past 18 months, Adelene Q Perkins made 1 insider transaction in Infinity Pharmaceuticals Inc (INFIQ) with a net sale of 410,196.

In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.

Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Infinity Pharmaceuticals Inc Insider Transactions

No Available Data

Adelene Q Perkins Mailing Address

Above is the net worth, insider trading, and ownership report for Adelene Q Perkins. You might contact Adelene Q Perkins via mailing address: C/o Infinity Pharmaceuticals, Inc., 780 Memorial Drive, Cambridge Ma 02139.